Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future. - Wikidata - wikimedia - TriplyDB

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.

http://www.wikidata.org/entity/Q37381677

about

Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.

P2860

Q37387665-F7C02A7A-5C3F-4966-9D42-BCE087C14ED9

P2860

Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.

http://www.wikidata.org/entity/Q37381677

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 January 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Disease Management - Construct ...... ns: Past, Present, and Future.

@en

Disease Management - Construct ...... ns: Past, Present, and Future.

@nl

type

label

Disease Management - Construct ...... ns: Past, Present, and Future.

@en

Disease Management - Construct ...... ns: Past, Present, and Future.

@nl

prefLabel

Disease Management - Construct ...... ns: Past, Present, and Future.

@en

Disease Management - Construct ...... ns: Past, Present, and Future.

@nl

P1433

Q37381677-CBFAD1C6-BEC3-479E-AD97-1AAEEFBCF125

P1476

Q37381677-68EDA3AF-8F98-4E78-901A-87C3FB7F19C8

P2093

Q37381677-F7806335-BBE9-4653-85B2-8E32379E0ABE

P2860

Q37381677-02B463C2-F488-4145-9166-B85CC7F386DB

Q37381677-02EBEE62-37C4-4822-97CC-EF39ACC9C5DD

Q37381677-0DB394EB-CDFD-4A5E-8190-FCC5D6F90EBB

Q37381677-0F5355C2-FEB4-46FA-80E3-6446282F57AB

Q37381677-22C93157-FC94-41CB-BED5-16CE37FDB8BA

Q37381677-22F1EAF5-A17F-49A4-9F2F-8D52D0A64757

Q37381677-2B1A952E-988A-4B14-8FBF-BFFE37A13072

Q37381677-2D681149-3160-477B-A8CB-62B9A772BF3A

Q37381677-3CDFACBE-9D5B-4BED-897D-AA5EA0045EBC

Q37381677-460633AB-8980-479B-8356-DD719C06F411

P2888

Q37381677-AD6DF3EC-A3F4-4098-86F1-D6B614996C97

P304

Q37381677-D759D341-72F8-4B89-8130-91E4DC46AB8E

P31

Q37381677-24DB1CA5-CB0D-4EC4-85CA-C308C8B53BD9

P356

Q37381677-D789D592-69FA-4C87-9594-4FBCC52E490D

P433

Q37381677-56DCB2DC-29FB-4FCA-8FA5-FBD0D8926873

P478

Q37381677-711D8189-7E06-468B-8B4A-2B7F9D9CA0B4

P577

Q37381677-0180EE51-83E6-4FEF-AD48-C73C19D7DF33

P5875

Q37381677-4A7DC1DE-D252-4B2A-AE1C-62FE802D540B

P6179

Q37381677-C6217F72-5499-4675-B9CB-A9EA35ABCAFA

P698

Q37381677-0ACBEA24-13CF-4F75-A0F9-328F64C5D35D

P932

Q37381677-A14525AD-0F2F-46AF-A82A-F5FB7697DA0C

P356

1758-2652-8-1-16

P1433

Journal of the International AIDS Society

P1476

Disease Management - Construct ...... ns: Past, Present, and Future.

@en

P2093

Douglas T Dieterich

http://www.w3.org/2001/XMLSchema#string

P2860

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.

NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.

P2888

1758-2652-8-1-16

P304

16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1758-2652-8-1-16

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6873004

http://www.w3.org/2001/XMLSchema#string

P6179

1007428870

http://www.w3.org/2001/XMLSchema#string

P698

19825136

http://www.w3.org/2001/XMLSchema#string

P932

2759642

http://www.w3.org/2001/XMLSchema#string